Popular topics
Where the capital lands, who writes the cheque, and what gets built with it. Funding rounds, venture capital flows, and the deal-making that shapes which technology companies scale.
6,929 articles · Funding
London-based Climate X, a climate risk intelligence company, announced that it has raised $18M (approximately €16.81M) in a Series A round of funding to accelerate its global expansion.
Berlin-based LiveEO, an earth observation company, announced on Tuesday that it has secured €25M in a Series B funding round led by NordicNinja and DeepTech & Climate Fonds (DTCF).
Belgium-based Chift, a provider of unified APIs for business software integrations, announced that it has raised €2.3M in a seed round of funding from investment firms and business angels to support its growth.
Vienna-based Prewave, an AI-powered supply chain intelligence startup, announced on Tuesday that it has secured $67M (approximately €63M) in a Series B funding round, led by the global investment firm Hedosophia.
Ghent-based Otamiser, a ranking management solution provider for the hospitality industry, has secured $3M (approximately €2.79M) in fresh funding.
Zug, Switzerland-based SkyCell, a company transforming the pharmaceutical supply chain, announced on Tuesday that it has closed $116M (approximately €108M) in a Series D funding round.
Ghent-based TechWolf, an AI company, announced on Tuesday that it has secured $42.75M (approximately €39.8M) in a Series B funding round led by Felix Capital.
Amsterdam-based Fastned, the fast-charging company, announced on Monday, June 24 that it has issued €32.9M of new bonds, with a 6 per cent coupon and a 5-year maturity.
Neustark, a Switzerland-based carbon removal company, announced that it has raised $69M (approximately €64.26M) in a growth equity round of funding.
Paris-based Hero, a new fintech startup that offers an all-in-one platform to accept payments and manage cash flow, announced that it has secured €11.3M in funding to address the gaps in financial solutions for small and medium enterprises (SMEs).
Leiden-based Vico Therapeutics, a clinical-stage genetic medicines company, announced on Monday that it has secured €11.5M funding in a second closing of a Series B financing round from Seroba and Kurma Partners.
Düsseldorf, Germany-based CUREosity, a MedTech company, announced on Monday that it has secured €3.8M in a growth financing round from existing and new investors.
